[{"indications": "Indications\u00a0hypertension (see notes above); benign\r\nprostatic hyperplasia (%s\n(From 7.4.1 Drugs for urinary retention: British National Formulary)\n7.4.1 Drugs for urinary retention)", "name": "INDORAMIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.5 Hypertension and heart failure", "2.5.4 Alpha-adrenoceptor blocking drugs", "INDORAMIN"], "cautions": "Cautions\u00a0avoid alcohol (enhances rate and\r\nextent of absorption); control incipient\r\nheart failure before initiating indoramin; elderly; Parkinson\u2019s disease (extrapyramidal\r\ndisorders reported); epilepsy (convulsions in animal studies); history\r\nof depression; cataract surgery (risk of\r\nintra-operative floppy iris syndrome); interactions: Appendix 1 (alpha-blockers)Driving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving); effects\r\nof alcohol may be enhanced", "side-effects": "Side-effects\u00a0see section 7.4.1; also\r\nsedation; less commonly fatigue, weight gain, failure\r\nof ejaculation; also reported extrapyramidal disorders, urinary frequency, and incontinence", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/9939.htm", "doses": ["Hypertension, initially 25\u00a0mg twice daily, increased by\r\n25\u201350\u00a0mg daily at intervals of 2 weeks; max. daily dose 200\u00a0mg in\r\n2\u20133 divided doses"], "pregnancy": "Pregnancy\u00a0no evidence of teratogenicity; manufacturers advise\r\nuse only when potential benefit outweighs risk"}, {"indications": "Indications\u00a0hypertension (see notes above); benign\r\nprostatic hyperplasia (%s\n(From 7.4.1 Drugs for urinary retention: British National Formulary)\n7.4.1 Drugs for urinary retention)", "name": "INDORAMIN - ALPHA-ADRENOCEPTOR BLOCKING DRUGS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.5 Hypertension and heart failure", "2.5.4 Alpha-adrenoceptor blocking drugs", "INDORAMIN"], "cautions": "Cautions\u00a0avoid alcohol (enhances rate and\r\nextent of absorption); control incipient\r\nheart failure before initiating indoramin; elderly; Parkinson\u2019s disease (extrapyramidal\r\ndisorders reported); epilepsy (convulsions in animal studies); history\r\nof depression; cataract surgery (risk of\r\nintra-operative floppy iris syndrome); interactions: Appendix 1 (alpha-blockers)Driving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving); effects\r\nof alcohol may be enhanced", "side-effects": "Side-effects\u00a0see section 7.4.1; also\r\nsedation; less commonly fatigue, weight gain, failure\r\nof ejaculation; also reported extrapyramidal disorders, urinary frequency, and incontinence", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/9939.htm", "doses": ["Hypertension, initially 25\u00a0mg twice daily, increased by\r\n25\u201350\u00a0mg daily at intervals of 2 weeks; max. daily dose 200\u00a0mg in\r\n2\u20133 divided doses"], "pregnancy": "Pregnancy\u00a0no evidence of teratogenicity; manufacturers advise\r\nuse only when potential benefit outweighs risk"}, {"indications": "Indications\u00a0 benign prostatic hyperplasia; hypertension\r\n(section 2.5.4)", "name": "INDORAMIN - ALPHA-BLOCKERS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "7 Obstetrics, gynaecology, and urinary-tract disorders", "7.4 Drugs for genito-urinary disorders", "7.4.1 Drugs for urinary retention", "Alpha-blockers", "INDORAMIN"], "cautions": "Cautions\u00a0\n(From Alpha-blockers: British National Formulary)\nCautions\u00a0Since alpha1-selective alpha blockers reduce blood pressure, patients receiving antihypertensive treatment may require reduced dosage and specialist supervision. Caution is required in the elderly and in patients undergoing cataract surgery (risk of intra-operative floppy iris syndrome). For interactions, see Appendix 1 (alpha-blockers). and %s\n(From INDORAMIN: British National Formulary)\nINDORAMIN", "side-effects": "Side-effects\u00a0\n(From Alpha-blockers: British National Formulary)\nSide-effects\u00a0Side-effects of alpha1-selective alpha blockers include drowsiness, hypotension (notably postural hypotension), syncope, asthenia, dizziness, depression, headache, dry mouth, gastro-intestinal disturbances, oedema, blurred vision, intra-operative floppy iris syndrome (most strongly associated with tamsulosin), rhinitis, erectile disorders (including priapism), tachycardia, and palpitations. Hypersensitivity reactions including rash, pruritus and angioedema have also been reported. and %s\n(From INDORAMIN: British National Formulary)\nINDORAMIN", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/13903.htm", "doses": ["20\u00a0mg twice daily; increased if necessary by 20\u00a0mg every\r\n2 weeks to max. 100\u00a0mg daily in divided doses; elderly, 20\u00a0mg at night may be adequate"]}]